Index -
P/E 3.35
EPS (ttm) 0.42
Insider Own 27.35%
Shs Outstand 53.00M
Perf Week -5.33%
Market Cap 76.52M
Forward P/E -
EPS next Y -0.78
Insider Trans -1.53%
Shs Float 39.15M
Perf Month -15.98%
Income 22.81M
PEG 0.09
EPS next Q -0.04
Inst Own 21.26%
Short Float 1.31%
Perf Quarter -9.55%
Sales 96.74M
P/S 0.79
EPS this Y -298.26%
Inst Trans -5.12%
Short Ratio 1.60
Perf Half Y 35.24%
Book/sh 2.02
P/B 0.70
EPS next Y 8.50%
ROA 14.85%
Short Interest 0.51M
Perf Year -16.96%
Cash/sh 1.42
P/C 1.00
EPS next 5Y 36.90%
ROE 24.95%
52W Range 0.99 - 2.00
Perf YTD -3.40%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI 20.60%
52W High -28.82%
Beta 0.62
Dividend TTM -
Quick Ratio 3.53
Sales past 5Y 586.08%
Gross Margin 99.13%
52W Low 43.43%
ATR (14) 0.09
Dividend Ex-Date -
Current Ratio 3.53
EPS Y/Y TTM 125.77%
Oper. Margin 20.41%
RSI (14) 33.71
Volatility 6.10% 5.45%
Employees 46
Debt/Eq 0.05
Sales Y/Y TTM 99.13%
Profit Margin 23.58%
Recom 1.50
Target Price 7.50
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 75.41%
Payout 0.00%
Rel Volume 0.34
Prev Close 1.43
Sales Surprise 294.58%
EPS Surprise 1060.00%
Sales Q/Q 54.95%
Earnings Mar 13 AMC
Avg Volume 320.11K
Price 1.42
SMA20 -12.75%
SMA50 -13.07%
SMA200 1.61%
Trades
Volume 110,042
Change -1.05%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-23-22 Upgrade
Evercore ISI
In-line → Outperform
$2 → $8
Oct-01-21 Downgrade
Oppenheimer
Outperform → Perform
Jan-22-21 Reiterated
H.C. Wainwright
Buy
$33 → $40
Dec-16-20 Initiated
Berenberg
Buy
$47
Sep-29-20 Initiated
Evercore ISI
Outperform
Nov-05-19 Reiterated
H.C. Wainwright
Buy
$28 → $35
Sep-09-19 Initiated
Janney
Buy
Feb-09-18 Initiated
Cantor Fitzgerald
Overweight
$27
Nov-27-17 Initiated
Stifel
Buy
$26
Nov-27-17 Initiated
Oppenheimer
Outperform
$30
Nov-27-17 Initiated
BofA/Merrill
Neutral
$16
Show Previous Ratings
Apr-16-24 11:52AM
Mar-15-24 12:51PM
Mar-14-24 06:33AM
(Thomson Reuters StreetEvents)
Mar-13-24 05:10PM
04:01PM
08:05AM
Loading…
Mar-06-24 08:05AM
Feb-28-24 08:05AM
Feb-26-24 08:05AM
Feb-05-24 11:27PM
Jan-31-24 04:05PM
Jan-29-24 04:07AM
Jan-25-24 04:40AM
Jan-05-24 08:05AM
Jan-02-24 08:05AM
Nov-14-23 09:02AM
04:05PM
Loading…
Nov-13-23 04:05PM
Nov-06-23 08:05AM
Nov-01-23 04:05PM
08:05AM
Oct-31-23 04:05PM
Oct-18-23 12:00PM
Sep-29-23 04:05PM
Sep-20-23 04:05PM
Sep-16-23 01:01PM
Sep-12-23 08:00AM
Sep-06-23 08:05AM
Aug-31-23 04:05PM
Aug-29-23 12:00PM
Aug-22-23 05:45PM
Aug-13-23 05:24AM
06:32AM
Loading…
Aug-11-23 06:32AM
(Thomson Reuters StreetEvents)
Aug-10-23 06:05PM
04:05PM
Aug-03-23 08:05AM
Jul-31-23 08:05AM
Jul-05-23 06:20AM
Jun-30-23 04:05PM
Jun-18-23 07:51PM
Jun-14-23 08:05AM
May-31-23 04:05PM
May-18-23 07:09AM
May-16-23 11:36AM
May-12-23 05:30AM
(Thomson Reuters StreetEvents)
May-11-23 05:35PM
04:05PM
May-04-23 08:05AM
Apr-28-23 04:05PM
Apr-26-23 08:05AM
Apr-17-23 07:14AM
Apr-14-23 08:05AM
Apr-13-23 06:19AM
Apr-05-23 09:59PM
Apr-01-23 09:07AM
Mar-31-23 04:05PM
Mar-30-23 06:05PM
04:05PM
Mar-13-23 08:05AM
Mar-06-23 08:05AM
Feb-28-23 04:05PM
08:05AM
Feb-23-23 09:35AM
Feb-22-23 09:35AM
Jan-31-23 04:05PM
Jan-14-23 08:03AM
Dec-22-22 04:05PM
Nov-22-22 08:05AM
Nov-16-22 05:55AM
Nov-14-22 05:25PM
04:05PM
Nov-08-22 08:05AM
Nov-07-22 08:05AM
Nov-02-22 10:01AM
Oct-19-22 08:05AM
Oct-03-22 08:05AM
Sep-25-22 07:00AM
Sep-23-22 11:02AM
Sep-22-22 11:30AM
(American City Business Journals) +167.74%
10:53AM
07:20AM
02:00AM
Sep-15-22 04:05PM
Sep-07-22 12:37PM
10:36AM
08:05AM
Sep-06-22 10:10AM
08:05AM
Sep-05-22 06:49AM
Aug-25-22 09:55AM
Aug-10-22 05:25PM
04:05PM
Aug-09-22 08:05AM
Jul-06-22 02:30AM
Jun-27-22 04:27PM
04:05PM
May-31-22 07:30AM
May-16-22 05:35PM
04:05PM
May-11-22 08:05AM
May-09-22 08:05AM
May-04-22 09:15AM
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Shukla Sath CEO and President Feb 05 '24 Sale 1.45 45,093 65,385 1,176,007 Feb 05 08:40 PM Mahadevia Ankit Director Feb 02 '24 Sale 1.37 63,795 87,399 744,997 Feb 05 08:50 PM JOSEPH TAMARA L Chief Legal Officer Feb 02 '24 Sale 1.37 30,906 42,341 531,615 Feb 05 08:48 PM Shukla Sath CEO and President Feb 02 '24 Sale 1.37 30,901 42,334 1,221,100 Feb 05 08:40 PM Keutzer Timothy Chief Operating Officer Feb 02 '24 Sale 1.36 30,971 42,121 534,050 Feb 05 08:53 PM HAMED KAMAL Chief Medical Officer Feb 02 '24 Sale 1.37 28,075 38,463 788,117 Feb 05 08:45 PM HAMED KAMAL Chief Medical Officer Sep 13 '23 Sale 1.27 39,496 50,160 576,461 Sep 15 05:47 PM Shukla Sath CEO and President Aug 29 '23 Sale 1.30 4,163 5,412 572,500 Aug 30 04:20 PM Mahadevia Ankit Director Aug 28 '23 Sale 1.26 9,040 11,390 788,792 Aug 30 04:21 PM JOSEPH TAMARA L Chief Legal Officer Aug 28 '23 Sale 1.26 1,854 2,336 322,790 Aug 30 04:22 PM Keutzer Timothy Chief Development Officer Aug 28 '23 Sale 1.26 1,854 2,336 325,290 Aug 30 04:23 PM Shukla Sath CEO and President Aug 28 '23 Sale 1.26 1,854 2,336 576,663 Aug 30 04:20 PM
Index RUT
P/E 4.28
EPS (ttm) 10.04
Insider Own 7.28%
Shs Outstand 100.76M
Perf Week 1.22%
Market Cap 4.33B
Forward P/E 7.08
EPS next Y 6.07
Insider Trans -0.48%
Shs Float 93.53M
Perf Month 8.76%
Income 922.97M
PEG -
EPS next Q 1.18
Inst Own 100.29%
Short Float 10.91%
Perf Quarter 26.79%
Sales 1.67B
P/S 2.59
EPS this Y -16.77%
Inst Trans 0.32%
Short Ratio 7.95
Perf Half Y 10.29%
Book/sh 20.32
P/B 2.11
EPS next Y 10.76%
ROA 25.08%
Short Interest 10.20M
Perf Year 27.36%
Cash/sh 0.08
P/C 528.58
EPS next 5Y -1.30%
ROE 66.09%
52W Range 29.57 - 43.64
Perf YTD 15.92%
Dividend Est. 1.60 (3.72%)
P/FCF -
EPS past 5Y 10.56%
ROI 23.77%
52W High -1.53%
Beta 1.84
Dividend TTM 1.55 (3.61%)
Quick Ratio 1.32
Sales past 5Y 55.24%
Gross Margin 40.58%
52W Low 45.32%
ATR (14) 0.89
Dividend Ex-Date Mar 27, 2024
Current Ratio 1.32
EPS Y/Y TTM 9.85%
Oper. Margin 37.73%
RSI (14) 71.89
Volatility 2.39% 2.06%
Employees 38
Debt/Eq 0.90
Sales Y/Y TTM -16.34%
Profit Margin 55.22%
Recom 1.46
Target Price 50.19
Option/Short Yes / Yes
LT Debt/Eq 0.90
EPS Q/Q 139.26%
Payout 14.86%
Rel Volume 0.90
Prev Close 43.11
Sales Surprise 42.90%
EPS Surprise -2.45%
Sales Q/Q -32.16%
Earnings Apr 30 BMO
Avg Volume 1.28M
Price 42.97
SMA20 3.57%
SMA50 12.37%
SMA200 13.01%
Trades
Volume 1,166,072
Change -0.32%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-24 Initiated
Morgan Stanley
Equal-Weight
$40
Jan-05-24 Downgrade
BofA Securities
Buy → Underperform
$39
Dec-14-23 Downgrade
Johnson Rice
Buy → Accumulate
Aug-14-23 Downgrade
Piper Sandler
Overweight → Neutral
$46
Jan-06-23 Upgrade
BofA Securities
Neutral → Buy
$38
Oct-19-22 Initiated
Jefferies
Buy
$37
Sep-19-22 Reiterated
BofA Securities
Neutral
$32 → $34
Mar-15-22 Upgrade
Johnson Rice
Accumulate → Buy
$50
Mar-14-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$34
Mar-08-22 Downgrade
BofA Securities
Buy → Neutral
$33 → $38
Dec-17-21 Upgrade
BofA Securities
Neutral → Buy
$28
Oct-14-21 Downgrade
BofA Securities
Buy → Neutral
$28 → $30
Jul-22-21 Upgrade
Piper Sandler
Neutral → Overweight
$22 → $23
Jun-23-21 Initiated
Piper Sandler
Neutral
$22
Jun-21-21 Resumed
BofA Securities
Buy
$21 → $24
Apr-16-21 Initiated
Citigroup
Buy
$17
Jan-26-21 Initiated
RBC Capital Mkts
Outperform
$14
Jan-07-21 Resumed
Raymond James
Strong Buy
$14
Sep-25-20 Initiated
Wells Fargo
Overweight
$10
Aug-27-20 Initiated
ROTH Capital
Buy
$1.80
Show Previous Ratings
Apr-23-24 10:00AM
Apr-16-24 04:10PM
Apr-04-24 07:00AM
Apr-03-24 04:45PM
Mar-01-24 07:00AM
09:10AM
Loading…
Feb-24-24 09:10AM
Feb-22-24 06:00PM
04:47PM
(Associated Press Finance)
04:38PM
04:05PM
Feb-15-24 04:05PM
10:00AM
Feb-09-24 05:58AM
Feb-06-24 04:05PM
Feb-05-24 04:05PM
04:05PM
Loading…
Jan-31-24 04:05PM
Jan-16-24 03:57PM
Jan-12-24 02:57AM
Dec-26-23 05:07AM
Dec-01-23 11:31AM
Nov-21-23 07:30AM
Nov-13-23 02:27PM
Nov-09-23 09:45AM
Nov-08-23 09:09AM
Nov-06-23 05:40AM
Nov-03-23 04:05PM
Nov-02-23 01:45PM
Nov-01-23 07:30PM
06:01PM
04:37PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Oct-30-23 04:05PM
Oct-26-23 10:02AM
Oct-25-23 12:54PM
10:02AM
07:30AM
Oct-12-23 04:05PM
Oct-11-23 08:42AM
Oct-10-23 08:57PM
04:09PM
Oct-09-23 11:01AM
Sep-27-23 07:03AM
Sep-19-23 03:48PM
Sep-18-23 05:02AM
Sep-14-23 08:28AM
05:12AM
Sep-13-23 08:04AM
Sep-07-23 07:00AM
Sep-06-23 08:00AM
Sep-01-23 11:31AM
Aug-15-23 04:05PM
Aug-14-23 09:02AM
Aug-07-23 08:15AM
Aug-05-23 12:32PM
08:10AM
Aug-04-23 08:04AM
Aug-02-23 10:00PM
06:15PM
05:04PM
04:10PM
04:00PM
Aug-01-23 04:05PM
Jul-31-23 11:28AM
Jul-28-23 08:52AM
Jul-26-23 01:30PM
10:02AM
Jul-25-23 07:02PM
Jul-18-23 09:45AM
Jul-12-23 05:13PM
Jul-03-23 10:12AM
Jun-30-23 04:05PM
Jun-27-23 05:18AM
Jun-26-23 08:55AM
Jun-19-23 08:01AM
Jun-15-23 08:05AM
07:30AM
May-15-23 09:57PM
04:13PM
04:11PM
07:28AM
May-08-23 04:11PM
07:36AM
May-07-23 01:18PM
May-04-23 06:15PM
04:15PM
May-01-23 04:15PM
Apr-27-23 10:02AM
Apr-20-23 10:19AM
Apr-19-23 06:30AM
Apr-14-23 09:35AM
09:28AM
Apr-13-23 08:48PM
Apr-10-23 04:15PM
Apr-05-23 09:03AM
06:27AM
Mar-08-23 02:02PM
Mar-06-23 06:30AM
Feb-27-23 10:29PM
Feb-25-23 05:32AM
(Thomson Reuters StreetEvents)
Feb-23-23 05:45PM
Northern Oil & Gas, Inc. engages in the acquisition, exploration, development, and production of crude oil and natural gas properties. It focuses on the Bakken and Three Forks formation within the Williston Basin in North Dakota and Montana. The company was founded by Michael Lewis Reger in 2006 and is headquartered in Minnetonka, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Evans James B. Chief Technical Officer Apr 09 '24 Sale 42.00 3,150 132,300 73,753 Apr 09 05:02 PM O'GRADY NICHOLAS L. CEO Apr 04 '24 Sale 40.98 3,750 153,656 228,082 Apr 04 04:18 PM Dirlam Adam A. President Apr 01 '24 Sale 39.88 1,392 55,513 111,804 Apr 03 04:16 PM Evans James B. Chief Technical Officer Apr 01 '24 Sale 39.88 630 25,124 76,903 Apr 03 04:17 PM Dirlam Adam A. President Apr 01 '24 Sale 39.88 204 8,136 18,339 Apr 03 04:16 PM Dirlam Adam A. President Mar 15 '24 Sale 38.00 2,088 79,344 122,359 Mar 19 04:07 PM Evans James B. Chief Technical Officer Mar 15 '24 Sale 38.00 945 35,910 83,872 Mar 19 04:06 PM Dirlam Adam A. President Mar 15 '24 Sale 38.00 306 11,628 20,678 Mar 19 04:07 PM Dirlam Adam A. President Mar 01 '24 Sale 36.12 696 25,140 110,044 Mar 05 05:40 PM Evans James B. Chief Technical Officer Mar 01 '24 Sale 36.12 315 11,378 77,616 Mar 05 05:40 PM Dirlam Adam A. President Mar 01 '24 Sale 36.12 102 3,684 13,924 Mar 05 05:40 PM Dirlam Adam A. President Feb 22 '24 Sale 35.00 696 24,360 110,740 Feb 26 04:19 PM Evans James B. Chief Technical Officer Feb 22 '24 Sale 35.00 315 11,025 77,931 Feb 26 04:18 PM Dirlam Adam A. President Feb 22 '24 Sale 35.00 102 3,570 14,026 Feb 26 04:19 PM O'GRADY NICHOLAS L. CEO Jan 09 '24 Sale 35.63 3,750 133,627 220,825 Jan 11 04:08 PM Evans James B. Chief Technical Officer Jan 02 '24 Sale 37.44 315 11,794 78,246 Jan 03 04:19 PM Dirlam Adam A. President Dec 01 '23 Sale 37.62 1,392 52,374 58,180 Dec 04 04:07 PM Evans James B. Chief Technical Officer Dec 01 '23 Sale 37.62 630 23,704 38,097 Dec 04 04:09 PM Dirlam Adam A. President Dec 01 '23 Sale 37.62 204 7,676 14,230 Dec 04 04:07 PM Akradi Bahram Director Nov 28 '23 Sale 37.83 12,000 453,943 0 Nov 29 04:01 PM Dirlam Adam A. President Nov 01 '23 Sale 38.49 1,392 53,578 59,572 Nov 03 04:07 PM Evans James B. Chief Technical Officer Nov 01 '23 Sale 38.49 630 24,249 38,727 Nov 03 04:07 PM Dirlam Adam A. President Nov 01 '23 Sale 38.49 204 7,852 14,434 Nov 03 04:07 PM Allen Chad W CFO Oct 16 '23 Sale 40.53 7,560 306,407 41,537 Oct 17 04:23 PM O'GRADY NICHOLAS L. CEO Oct 09 '23 Sale 39.96 28,950 1,156,842 147,697 Oct 10 07:31 AM Evans James B. Chief Technical Officer Oct 09 '23 Sale 39.79 630 25,068 39,357 Oct 10 07:31 AM Dirlam Adam A. President Oct 02 '23 Sale 40.28 1,392 56,070 60,964 Oct 03 04:01 PM Dirlam Adam A. President Oct 02 '23 Sale 40.28 204 8,217 14,638 Oct 03 04:01 PM Dirlam Adam A. President Sep 18 '23 Sale 40.50 1,392 56,376 62,356 Sep 20 04:05 PM Dirlam Adam A. President Sep 18 '23 Sale 40.50 204 8,262 14,842 Sep 20 04:05 PM Romslo Erik J. Chief Legal Officer & Sec. Aug 25 '23 Sale 40.73 7,500 305,494 80,036 Aug 28 04:16 PM Akradi Bahram Director Aug 07 '23 Sale 41.93 110,291 4,624,579 1,600,000 Aug 09 04:11 PM Allen Chad W CFO Aug 03 '23 Sale 40.32 4,800 193,549 49,097 Aug 04 04:05 PM Evans James B. Chief Technical Officer Aug 03 '23 Sale 40.45 4,000 161,812 39,987 Aug 04 04:05 PM Evans James B. Chief Technical Officer Jul 31 '23 Sale 40.00 1,000 40,003 43,987 Aug 01 05:16 PM Allen Chad W CFO Jul 31 '23 Sale 40.02 200 8,003 53,897 Aug 01 05:17 PM O'GRADY NICHOLAS L. CEO Jul 27 '23 Sale 39.06 22,500 878,742 177,255 Jul 31 06:49 AM
Index -
P/E -
EPS (ttm) -0.44
Insider Own 66.69%
Shs Outstand 9.07M
Perf Week 1.13%
Market Cap 24.40M
Forward P/E -
EPS next Y -
Insider Trans 0.00%
Shs Float 3.02M
Perf Month -1.10%
Income -4.01M
PEG -
EPS next Q -
Inst Own 2.36%
Short Float 0.42%
Perf Quarter -9.12%
Sales 15.75M
P/S 1.55
EPS this Y -
Inst Trans -8.09%
Short Ratio 4.12
Perf Half Y -26.90%
Book/sh 5.87
P/B 0.46
EPS next Y -
ROA -6.19%
Short Interest 0.01M
Perf Year -30.31%
Cash/sh 6.38
P/C 0.42
EPS next 5Y 22.00%
ROE -9.48%
52W Range 2.40 - 4.15
Perf YTD -21.80%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -7.33%
52W High -35.18%
Beta 0.42
Dividend TTM -
Quick Ratio 3.09
Sales past 5Y -28.10%
Gross Margin 27.87%
52W Low 12.08%
ATR (14) 0.19
Dividend Ex-Date -
Current Ratio 3.14
EPS Y/Y TTM 21.61%
Oper. Margin -43.20%
RSI (14) 51.09
Volatility 4.02% 7.49%
Employees -
Debt/Eq 0.05
Sales Y/Y TTM 12.32%
Profit Margin -25.48%
Recom 1.00
Target Price 10.00
Option/Short No / Yes
LT Debt/Eq 0.03
EPS Q/Q -263.69%
Payout -
Rel Volume 0.13
Prev Close 2.73
Sales Surprise -
EPS Surprise -
Sales Q/Q 11.45%
Earnings -
Avg Volume 3.10K
Price 2.69
SMA20 1.91%
SMA50 -1.10%
SMA200 -18.21%
Trades
Volume 418
Change -1.47%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-31-15 Initiated
Northland Capital
Outperform
$2.50
Sep-17-10 Initiated
Auriga U.S.A
Buy
$3
Feb-27-09 Reiterated
Jefferies & Co
Underperform
$1.50 → $0.75
Feb-27-09 Downgrade
BWS Financial
Buy → Hold
Sep-18-08 Upgrade
BWS Financial
Hold → Buy
Aug-07-08 Downgrade
Jefferies & Co
Hold → Underperform
$4.50 → $3.60
Aug-07-08 Downgrade
BWS Financial
Buy → Hold
$6 → $4.50
Dec-10-07 Reiterated
BWS Financial
Buy
$10 → $6
Jun-04-07 Reiterated
BWS Financial
Buy
$15 → $10
Mar-26-24 06:16AM
Mar-22-24 06:18AM
Aug-30-23 06:48AM
Apr-27-23 04:40PM
Mar-27-23 06:16AM
(Simply Wall St.) +13.22%
08:06AM
Loading…
Mar-24-23 08:06AM
Jan-04-23 06:00AM
Sep-02-22 06:06AM
06:00AM
Jul-29-22 08:55AM
Jul-15-22 06:00AM
Jun-30-22 06:00AM
Jun-28-22 06:00AM
May-27-22 09:50AM
May-18-22 06:00AM
06:00PM
Loading…
May-11-22 06:00PM
Apr-26-22 04:05PM
Mar-24-22 06:54AM
Jan-28-22 07:30AM
Jan-04-22 05:33AM
Nov-19-21 06:00AM
Sep-16-21 06:00AM
Aug-13-21 06:00AM
06:00AM
Jun-29-21 10:01AM
May-24-21 05:30AM
Apr-21-21 09:31AM
Mar-30-21 09:13AM
Mar-25-21 07:52AM
Feb-08-21 08:30AM
03:15PM
Loading…
Jan-11-21 03:15PM
06:00AM
Dec-31-20 06:00AM
Dec-28-20 06:00AM
Dec-11-20 06:54AM
Nov-06-20 06:00AM
Oct-30-20 05:00PM
Sep-29-20 05:50AM
Sep-01-20 08:40AM
Aug-31-20 06:00AM
May-20-20 06:00AM
Apr-29-20 08:00AM
Apr-28-20 05:00PM
Apr-10-20 10:37AM
Mar-27-20 06:00AM
Mar-16-20 06:00AM
Nov-27-19 12:11AM
(Thomson Reuters StreetEvents)
Nov-15-19 08:25AM
Nov-08-19 07:30AM
06:00AM
Nov-01-19 10:30AM
06:40AM
06:00AM
Oct-31-19 08:58AM
Oct-30-19 09:18AM
Oct-25-19 07:45PM
Oct-15-19 11:08AM
Oct-01-19 08:07AM
Sep-27-19 09:02AM
Sep-18-19 08:40AM
Sep-17-19 08:44AM
Aug-23-19 08:24AM
Aug-20-19 07:55PM
(Thomson Reuters StreetEvents)
Aug-13-19 05:35PM
04:15PM
Aug-05-19 06:00AM
Aug-02-19 09:37AM
Jul-17-19 10:29PM
May-23-19 07:01PM
(Thomson Reuters StreetEvents)
May-10-19 09:37AM
07:45AM
06:36AM
06:30AM
May-03-19 10:30AM
06:00AM
Apr-17-19 06:00PM
Mar-22-19 04:09PM
(Thomson Reuters StreetEvents)
Mar-15-19 06:20AM
06:00AM
Mar-08-19 06:00AM
Feb-13-19 06:00AM
Feb-10-19 04:42AM
Jan-21-19 06:00AM
Jan-14-19 06:00AM
Nov-09-18 11:27AM
(Thomson Reuters StreetEvents)
06:07AM
06:00AM
05:00AM
Nov-05-18 06:00AM
Sep-12-18 06:00AM
Sep-11-18 08:21AM
Aug-15-18 09:35PM
(Thomson Reuters StreetEvents)
Aug-03-18 06:11AM
06:00AM
06:00AM
Jul-27-18 06:00AM
Jul-24-18 06:00AM
Jul-19-18 06:00AM
May-18-18 07:39PM
May-14-18 03:04AM
(Thomson Reuters StreetEvents)
UTStarcom Holdings Corp. is a telecom infrastructure company, which develops technology for cloud-based services, mobile, streaming, and other applications. It operates through the following segments: Equipment, and Services. The Equipment segment focuses on equipment sales including network infrastructure and application products, which include broadband products, wireless infrastructure technologies. The Services segment provides services and support for equipment products and also the new operational support segment. The company was founded in 1991 and is headquartered in Hangzhou, China.
Index -
P/E -
EPS (ttm) -
Insider Own 59.69%
Shs Outstand 7.07M
Perf Week 1.69%
Market Cap 12.73M
Forward P/E -
EPS next Y -
Insider Trans 14.09%
Shs Float 2.85M
Perf Month -2.44%
Income -
PEG -
EPS next Q -
Inst Own 2.65%
Short Float 0.55%
Perf Quarter -9.55%
Sales -
P/S -
EPS this Y -
Inst Trans -40.52%
Short Ratio 1.40
Perf Half Y -43.96%
Book/sh 13.45
P/B 0.13
EPS next Y -
ROA -
Short Interest 0.02M
Perf Year -55.93%
Cash/sh 0.98
P/C 1.84
EPS next 5Y -
ROE -
52W Range 1.64 - 9.36
Perf YTD -25.06%
Dividend Est. -
P/FCF -
EPS past 5Y 22.12%
ROI -
52W High -80.77%
Beta 1.65
Dividend TTM 0.00 (0.00%)
Quick Ratio 0.38
Sales past 5Y -
Gross Margin -
52W Low 9.42%
ATR (14) 0.12
Dividend Ex-Date -
Current Ratio 0.46
EPS Y/Y TTM 27.08%
Oper. Margin -87.28%
RSI (14) 46.15
Volatility 3.23% 6.30%
Employees -
Debt/Eq 0.66
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 30.43
Option/Short No / Yes
LT Debt/Eq 0.16
EPS Q/Q 39.55%
Payout -
Rel Volume 0.81
Prev Close 1.73
Sales Surprise -
EPS Surprise -
Sales Q/Q -64.47%
Earnings -
Avg Volume 11.18K
Price 1.80
SMA20 -3.21%
SMA50 -3.87%
SMA200 -41.81%
Trades
Volume 9,111
Change 4.00%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-24-20 Initiated
Aegis Capital
Buy
$14
Jul-22-13 Initiated
Dawson James
Buy
$4
Jan-30-24 08:05AM
Jan-04-24 08:15AM
Dec-22-23 04:30PM
Nov-28-23 08:10AM
Nov-15-23 01:57PM
08:00AM
Loading…
Nov-14-23 08:00AM
Nov-08-23 08:31AM
Oct-26-23 05:25PM
Oct-23-23 08:25AM
Oct-12-23 08:25AM
Sep-06-23 08:40AM
Aug-29-23 05:40AM
Jul-31-23 08:15AM
Jul-27-23 09:00AM
Jul-12-23 09:00AM
08:15AM
Loading…
Jul-05-23 08:15AM
Jun-30-23 09:34AM
Jun-27-23 09:15AM
Jun-26-23 08:20AM
Jun-13-23 07:00AM
May-17-23 11:07AM
(Zacks Small Cap Research)
May-16-23 09:00AM
May-01-23 08:25AM
Apr-19-23 09:08AM
Apr-18-23 07:00AM
Apr-17-23 10:00AM
Apr-11-23 09:10AM
(Zacks Small Cap Research)
Mar-27-23 09:00AM
Mar-22-23 08:05AM
(Zacks Small Cap Research)
Mar-13-23 09:25AM
09:25AM
Loading…
Mar-07-23 09:25AM
Mar-02-23 08:30AM
Nov-17-22 10:05AM
(Zacks Small Cap Research)
Oct-19-22 08:00AM
Sep-22-22 09:15AM
(Zacks Small Cap Research) -7.89%
Aug-30-22 04:45PM
Jul-26-22 08:00AM
Jul-21-22 05:00PM
Jul-13-22 08:00AM
Jun-28-22 08:00AM
Jun-07-22 07:00AM
May-19-22 11:10AM
(Zacks Small Cap Research)
May-06-22 08:30AM
Apr-07-22 10:15AM
(Zacks Small Cap Research)
Mar-03-22 08:00AM
Feb-28-22 05:15PM
08:00AM
Feb-22-22 05:00PM
Jan-25-22 04:30PM
Jan-20-22 08:45AM
Jan-19-22 03:57PM
12:13PM
Jan-12-22 08:30AM
Jan-11-22 10:00AM
Jan-10-22 08:30AM
Jan-03-22 11:04AM
(Zacks Small Cap Research) +11.04%
Dec-22-21 07:30AM
Dec-20-21 10:10AM
Dec-15-21 07:30AM
Dec-07-21 07:30AM
07:00AM
Dec-01-21 05:15AM
(Zacks Small Cap Research)
Nov-30-21 07:30AM
Nov-04-21 09:00AM
Oct-28-21 08:00AM
Oct-20-21 08:00AM
Oct-05-21 08:00AM
Sep-20-21 07:30AM
Sep-13-21 09:32AM
Sep-09-21 07:00AM
Sep-08-21 07:00AM
Sep-07-21 08:00AM
Sep-02-21 06:25AM
(Zacks Small Cap Research)
Aug-23-21 01:52PM
09:00AM
Aug-17-21 08:30AM
Aug-02-21 09:45AM
Jul-27-21 08:00AM
Jul-12-21 08:00AM
Jul-06-21 08:30AM
Jun-30-21 08:30AM
Jun-24-21 09:10AM
Jun-17-21 10:00AM
09:46AM
Jun-16-21 09:00AM
Jun-15-21 08:54AM
Jun-14-21 08:08PM
May-24-21 09:31AM
May-20-21 12:15PM
(Zacks Small Cap Research)
May-19-21 08:30AM
May-11-21 08:45AM
Apr-21-21 06:55AM
Apr-19-21 05:00AM
(Zacks Small Cap Research)
Apr-08-21 09:05AM
Apr-07-21 09:15AM
Apr-06-21 12:39PM
09:05AM
Mar-31-21 08:15AM
Mar-01-21 07:30AM
05:43AM
(Zacks Small Cap Research)
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wu William Wai Leung Director Dec 29 '23 Sale 0.13 150,000 19,650 0 Jan 02 04:15 PM Wu William Wai Leung Director Dec 29 '23 Sale 0.13 1,020 134 0 Jan 02 04:15 PM Chan Heng Fai Ambrose Director Dec 28 '23 Buy 0.15 672,173 98,137 19,586,499 Jan 02 09:10 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite